WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Zai Lab Limited resulting from allegations that Zai Lab. | June 8, 2023
New translational and clinical biomarker data from Zai Lab’s global oncology program ZL-1211 will be featured in a poster presentation SHANGHAI and CAMBRIDGE, Mass., April 11, 2023 Zai Lab. | April 11, 2023